Market Research Reports

Tuesday 28 December 2021

Hospital Furniture Market Investment Feasibility, Share, Demand By 2027

Hospital Furniture Market Overview

Hospital furniture is also critical in changing a hospital environment into a comfortable public space for patients. The hospital furniture market will continue to thrive as long as hospitals are considered a civic obligation and public institutions. As per MRFR, the Hospital furniture market is estimated to gain a CAGR of 9.8% in the duration of the forecast period.

The need for more advanced hospitals and public agencies' efforts to modernize the infrastructure of existing hospitals are also propelling the hospital furniture market. The diagnosis and treatment of new diseases is also a key opportunity for the hospital medical furniture market, enabling it to concentrate on specialized treatment clinics.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1007

Segmental Analysis

Types, applications, and end-users are used to segment the hospital furniture market. The hospital furniture market can be divided into OT tables, hospital beds, chairs, scrub sinks, instrument stands, bedside tables, stretchers, trash containers, trolleys, and other categories based on type. The hospital furniture market is divided into three application categories: patient furniture, physician furniture, and staff furniture. The hospital furniture market comprises diagnostic centers, clinics, and hospitals based on end-users.

Detailed Regional Analysis

According to hospital furniture industry tendencies, the North American region accounts for most of the industry's size. Moreover, healthcare furniture trends show that the Asia Pacific area would be the fastest-growing industry during the forecast period. This trend can be traced back to hospital furniture makers in India and China. The African and European regional markets are already becoming increasingly important in the hospital furniture industry. Europe is undergoing a radical shift due to similar characteristics to the Americas. The APAC region is growing rapidly, and it will increase at the greatest rate during the projected period. Emerging economies are investing massively in healthcare infrastructure, and governments take the necessary steps to improve the sector. Furthermore, various nations in the region are establishing themselves as medical hubs, boosting the industry forward.

Competitive Analysis

The market is projected to witness an improvement in growth cues in the near future. The reclaimed market potential is projected to augment the worldwide market's progress. The market's production stability is predicted to be variable. Each manufacturer is expected to make microeconomic decisions to ensure long-term business growth and continuity during the forecast timeframe. The COVID-19 pandemic's drastic changes in the global financial intermediation structure are believed to influence how firms acquire finance in the comparable period. The essential policies being developed by government bodies worldwide are thought to have a powerful role in the global advancement of the market. The restructuring of the market's fundamental operations is expected to impact the market shortly. The upsurge in innovative technologies in the global supply chain is estimated to generate opportunities during the forecast period. The mindset of hypervigilance in the aftermath of the pandemic is intended to guide market decisions throughout the projected period.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/hospital-furniture-market-1007

The foremost companies in the hospital furniture market are Bio Medical Solutions (India), KI (US), The Brewer Company (US), Anetic Aid Limited (UK), DRE INC (US), Ocura Healthcare Furniture (UK), Bristol Maid Hospital Metalcraft (UK), GPC Medical Ltd (India), Chang Gung Medical Technology (China), Stryker Corporation (US), Narang Medical (India), Moore Medical LLC (US), and Hill-Rom (US).

Industry Updates:

Medikabazaar, a B2B online marketplace for medical products, has raised $75 million in a Series C round of funding led by Creaegis Principals LLP, a local private equity firm. Creaegis has acquired CDC Group Plc of the United Kingdom as a new investor. Avendus advised Medikabazaar on the deal. The money raised will help the company expand its international operations and strengthen its position in the Indian B2B health tech market. Medical equipment, medical gadgets, consumables, disposables, and hospital furniture are among the items listed on the platform.

Browse Related Reports at:

Global Organ-on-a-chip Market Research Report - Global Forecast till 2027

Global Pharmacy Management System Market Research Report—Forecast till 2027

Global Life Science Analytics Market Research Report—Forecast till 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Precision Medicine Market Insights, Emerging Trends and Landscape To 2027

Market Overview

The precision medicine market is estimated to reach around USD 126.14 billion at CAGR of 12.48% during the forecast period (2017-2025). Since the last few years, the healthcare industry has seen an explosion in the use of precision medicine. When the term "tailored medicines" was coined in 2003, it quickly became synonymous with precision medicine. Departments of medicine working on the complete sequencing of the human genome are primarily concerned with providing patients with personalized medications. New medical, scientific, and business models have emerged as a result of modern and advanced technological breakthroughs.

Rapid advances in technology, such as ultra-high-throughput and next-generation sequencing, will determine the future of precision medicine. The business potential for personalized medicine is reaching new heights as a result of the increasing prevalence of various hereditary disorders. The combination of biotech and pharmaceutical sectors with big data healthcare firms will drive the expansion of the precision medicine market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/925

Precision medicine's upward trajectory will be bolstered by further advances in the field. The fusion of biotech and pharmaceutical industries with bigdata health care enterprises is another factor that will raise the market value of the precision medicine industry in the near future.

Segmental Analysis

There are numerous submarkets, therapies, and stakeholders in the worldwide precision medicine industry.

Companion diagnostics, PGX (pharmacogenomics) and many more segments are included in the market segmentation of biomarker-based testing.

Treatments such as cardiovascular disease or CVD, central nervous system cancer or oncology and infectious illness are all part of the global precision medicine market sector.

The players in the ecosystem include diagnostics companies, pharmaceutical and biotechnology companies, clinical laboratories, healthcare IT specialists, and big data enterprises.

Region Overview

Several regions, including the Americas, Asia Pacific, Europe and Africa, are studied in the precision medicine market.

The global market will be dominated by the Americas. Prevalence of cancer and genetic disorders, the growing use and presence of important businesses such as Pfizer, Qiagen and Quest Diagnostics in the North American precision medicine industry accounted for majority of revenue share. Precision medicine awareness in the region and an increase in demand for individualised cancer treatment are expected to drive industry revenue in the region. The U.S. market for personalised medicine is expected to grow at the quickest rate in the global market, thanks to improved gene mapping technology.

Diagnostics, drugs, and electronic health records are all more advanced in Europe, which is why it is the market's second-largest regional market.

The most rapid expansion is predicted to occur in the Asia-Pacific region. One-size-fits-all medicine is increasingly being replaced by precision medicine, and these trends, as well as rising healthcare spending and research funding, are all projected to contribute to the expansion of the Asia-Pacific precision medicine software market. It is expected that the precision medicine industry in Singapore will surpass all other Asian markets in the next years as a result of rising disposable income and enhanced healthcare infrastructure.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/precision-medicine-market-925

Competitive Dynamics

The notable players of the market are Abbott Laboratories (USA), Ab-Biotics Sa (USA), Almac Group Ltd. (UK), Asuragen Inc (USA), Biobase Gmbh (Germany), Biomérieux Sa (France), Caris Life Sciences (USA), Cepheid Inc. (USA), Cetics Healthcare Technologies Gmbh (Germany), Ge Healthcare (USA), Glaxosmithkline PLC (UK), Healthcore Inc. (USA), IBM (USA), Innventis (Israel), Intel Corporation (USA), Johnson & Johnson (USA), Laboratory Corporation Of America Holdings (USA), Medtronic (USA), Molecular Health Gmbh (Germany), Novartis (Switzerland), Pfizer Inc. (USA), Qiagen (Germany), Quest Diagnostics Inc (USA), Randox Laboratories Ltd. (UK), Sanofi Pharma (France), Takeda Pharmaceutical Company Limited (Japan), and Teva Pharmaceutical Industries Ltd. (Israel).

Browse Related Reports at:

Global Life Science & Analytical Instruments Market Research Report—Forecast till 2027

Global Asthma Inhaler Device Market Research Report—Forecast till 2027

Global Acute Pancreatitis Market Research Report—Forecast till 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cancer Biomarker Market Segmentation, SWOT Analysis and Dynamics | Forecast to 2027

Market Scope

Market Research Future (MRFR) reveals that the cancer biomarker market would obtain a growth rate of 15.8% from 2020 to 2027. Rapidly mounting cases of cancer in the wake of surging prevalence of unhealthy living and bad eating habits will favor the cancer biomarkers market the years ahead. Rise in technological advances facilitate the combination of cancer biomarkers with several novel medications for faster and more accurate diagnosis along with improved treatments.

The strong influence of the western culture in the emerging counties, exhaustive research based on cancer biomarkers, and the FDA encouraging the development of biomarkers also add to the market worth. These biomarkers facilitate better speed and precision of diagnosis, which also helps foster their demand. Significant investments by private firms and the government in extensive cancer-related research/clinical trials, and the focus on developing highly specific drugs will further benefit the worldwide market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5378

Furthermore, the heightened number of government initiatives focused on cutting down the high healthcare costs through personalized medicines, for elevated focus on faster detection and prevention will also enhance the market share. Other than that, the escalating number of distributors, manufacturers and service providers of cancer biomarkers will give rise to lucrative opportunities in the coming years.

Majority of the companies adopt strategic measures including acquisitions, mergers, product innovation, and awareness campaigns that boost brand awareness. For instance, in April 2021, Amgen developed Biomarker Assist, which is a campaign to assist more patients affected by metastatic non-small cell lung cancer to get easier access to biomarker testing.

Market Segmentation

Major types of cancer biomarkers are genetic biomarker, protein biomarker, and more. The highest position has been taken by the genetic biomarker segment, which will continue to lead the market all through the given period. This segment is backed by the rising advances in technologies used for mutation detection, and the surge in innovations in high-throughput technologies. With major companies launching technologically-developed products, the accuracy and speed of genetic biomarker for diagnosis applications has improved significantly, giving a solid push to the segment.

Key applications of cancer biomarkers are cancer prognostic, therapeutic, as well as diagnostic. The diagnostic-based segments can be imaging along with non- Imaging.

Top end-users listed are diagnostic tool companies, pharmaceutical and biotechnology companies, clinical laboratories, healthcare big data companies, and more.

Regional Study

North America is the most successful market for cancer biomarkers, in terms of expansion, since the region has a highly developed pharmaceutical and healthcare sectors. The solid demand for cancer biomarkers in the United States is the result of the blossoming elderly patient populace and the resultant increase in the need for faster detection and treatment. The huge prevalence of cancer also fuels the market growth rate in the region.

Asia Pacific will potentially be the fastest developing market in the next few years, as a result of the substantial contributions from rapidly emerging nations like Australia, India, South Korea, Japan, and China. The region shall present attractive opportunities in the following years, as the number of contract research organizations continues to mount. Meanwhile, the low spending required to conduct clinical trials in the region facilitates business growth too. Widespread deployment of advanced medical imaging systems, rising healthcare expenditure and the massive rise of R&D scope with respect to cancer biomarkers could be a key growth inducer in the ensuing years.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378

Market Participants

MRFR has listed a few important cancer biomarker developers active in the worldwide market, including Abbott Laboratories (U.S.), Bristol-Myers Squibb (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Becton Dickinson (U.S.), GlaxoSmithKline plc. (U.S.), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Illumina Inc. (U.S.), QIAGEN N.V (U.S.), F. Hoffmann-La Roche AG (Switzerland), and more.

Browse Related Reports at:

Global Peripheral Artery Disease Market Research Report—Forecast till 2027

Global Breast Lesion Localization Market Research Report—Forecast till 2027

Global Patient Blood Management Market Research Report—Forecast till 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Menopause Treatment Market Demand, Sales, Profit Till 2027

Menopause Treatment Market Overview

The menopause treatment market is likely to record a healthy CAGR of over 6.18% over the assessment period from 2020 to 2027. The market is projected to acquire a market size of approximately USD 15,456.3 Million by 2027.

Menopause is a natural process with treatments that focus on symptomatic relief. Vaginal dryness is treated with estrogen or topical lubricants. Medications can lessen the frequency and severity of hot flushes. The global menopause treatment market has been witnessing massive growth in recent times. The extensive R&D activities are driving the market's growth to launch novel drugs, rising menopausal symptoms, growing disposable income of women, and availability of herbal treatment for menopause. However, the market's growth is likely to be restricted by the low awareness, low-income levels, considerable gender-wise health disparities, and lack of advanced healthcare infrastructure.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4579

Segment Analysis

The global menopause treatment market is divided into several segments based on treatment, distribution channel, and region.

Based on treatment, the menopause treatment market is split into anti-depressants, hormonal treatment, non-hormonal treatment, estrogen, combination, progesterone, and others.

The menopause treatment market is bifurcated into online stores, retail pharmacies, and hospital pharmacies based on the distribution channels.

Regional Analysis

The menopause treatment market is studied across four major regions, including the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The American regional market for menopause treatment dominated the market globally in 2019. The well-established healthcare industry is driving the regional market's growth with modern infrastructure, new drug launches, and the growth in urogenital complications and vasomotor symptoms among women. Furthermore, the rising introduction of novel drugs, high prevalence of an unhealthy lifestyle, increased awareness, supportive government initiatives, and the constantly growing female population aged over 60 are also likely to boost the regional market's growth.

The Asia-Pacific regional market for menopause treatment is likely to register the highest growth over the review timeframe. The regional market's growth is attributed to the rising instances of players entering joint ventures with the local firms and the mounting awareness level about women's health. Furthermore, the growing technological literacy and growth in the working women population are projected to accelerate the regional menopause treatment market over the review timeframe.

Competitive Analysis

The global menopause treatment market has an intensely competitive landscape. The growing R&D activities and therapies for menopause are likely to encourage new players to join the market. The players across the market are adopting several new strategies such as expansions, collaborations, joint ventures, acquisitions, and FDA approvals. The list of leading players in the menopause treatment market includes companies such as Novo Nordisk A/S (Denmark), Cipla Inc. (India), Abbott Laboratories (U.S.), Pfizer Inc. (U.S.), Merck & Co. Inc. (U.S.), Allergan (Ireland), Teva Pharmaceuticals (Israel), Eli Lily and Company (U.S.), Novartis AG (Switzerland), Emcure Pharmaceuticals Ltd (India), and many others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579

Recent Developments

December 2021 – a leader in women's health innovation, Daré Bioscience, Inc., announced that XACIATO [zah-she-AH-toe] got approval from the U.S. Food and Drug Administration (FDA) to treat bacterial vaginosis in females 12 years of age and older.

December 2021 – a leading real-world evidence company, Syapse®, devoted to extinguishing the fear and burden of severe diseases by progressing real-world care, presented five abstracts at the leading global conference for health economics and outcomes research (HEOR), Virtual ISPOR Europe 2021. Chief commercial officer at Syapse, David Pomerantz said that the company is proud to have a strong presence and to be sharing such crucial work at this year's Virtual ISPOR Europe meeting.

Browse Related Reports at:

Global Dental Chair Market Research Report—Forecast till 2027

Global Neurorehabilitation Devices Market Research Report—Forecast till 2027

Global Hyperspectral Imaging System Market Research Report—Forecast till 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Neuromodulation devices Market Overview, Opportunities and Applications By 2027

Market Scope

Neuromodulation devices market will be thriving at a rate of 11.2% during the forecast period, believes Market Research Future (MRFR). Neuromodulation devices have major applications in the treatment of tremors, a nerve disorder marked by uncontrollable shaking of numerous parts of the body including arms, hands, larynx (voice box), head, chin, and tongue. Almost a million people aged more than 40 years are suffering from tremors and undergoing treatment. The condition impairs daily activities, such as drinking, eating, writing, and more. Several implantable deep brain stimulators are increasingly being used to manage tremors. This shall be a key growth rendering factor in the next several years. Additionally, rising cases of this disorder, technological advances in neurostimulator devices, and the surge in FDA approvals for neuromodulation devices will foster the market value in the future.

Spinal cord stimulation helps in the treatment of chronic back pain. Nearly 30% of adults in the United States are experience chronic pain. In recent years, the USFDA and various other regulatory agencies have granted approval to several devices and drugs of the SCS technology, including Proclaim Elite SCS by St. Jude Medical, and Senza SCS System by Nevro Corporation. The extensive use of this technology boosts new indications like refractory angina pectoris, failed-back surgery syndrome, complex regional pain syndrome, and peripheral vascular disease, and more. The global market shall also benefit from the surging adoption in emerging countries for applications in neurological disorders, like Parkinson’s disease with no known cure. These devices are also enjoying significant demand for treatment of treatment-resistant depression, severe obsessive-compulsive disorder, and movement disorders, and Alzheimer's type dementia.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1337

Players are actively involved in adopting marketing strategies such as alliances, product range diversification, bolstering distribution channels and new launches to expand their global reach. To illustrate, in December 2021, Avivomed Inc., a medical device firm completed the Series A Preferred Stock fund of around USD 32 million. A consort of world-class medical device investors financed the company. The proceeds will allow the company to gain resources required for the development as well as commercialization of advanced neuromodulation technology solutions for treating massive patient pools affected by various chronic diseases.

Market Segmentation

The neuromodulation device types in the market are internal as well as external.

Major applications of neuromodulation devices are Spinal Cord Stimulation, and deep brain stimulation. Depending on spinal cord stimulation, the segments are Failed Back Syndrome (FBSS), Ischemia, and Chronic Pain Management.

With respect to biomaterial, the major segments can be ceramic biomaterials, polymeric biomaterials, and metallic biomaterials.

The end-users considered in the review study are home healthcare, clinics, as well as hospitals.

Regional Study

North America’s share in the global market is around 55%, higher than other regions, making it the top performer and consumer of neuromodulation devices. The dramatic surge in the cases of epilepsy, chronic pain, and other disorders has raised the need for advanced neuromodulation devices. These neurological diseases are especially common among the burgeoning aging population in the region. The strong market performance can also be accredited to the government and healthcare authorities spending considerably on exhaustive research & development activities. The expansive pool of renowned firms and the frequent FDA approvals also encourage market growth in the region.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/neuromodulation-devices-market-1337

APAC is all set to be a lucrative market in the forecast period, given the massive patient pool suffering from neurological diseases like epilepsy and Alzheimer. The surge in government initiatives in this regard, and improve the overall healthcare infrastructure also bolsters the growth. China export and import value and volume share in the region is considerable, in view of the advancing reimbursement scenario and the rising disposable income. India is another strong contender in the region, , owing to the spike in various neurological disorders, growth in the elderly population and the increasing healthcare expenditure.

Affluent Industry Contenders

LivaNova PLC (UK), Aleva Neurotherapeutics SA (U.S.), Bioness Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Nevro Corporation (U.S.), Boston Scientific Corporation (U.S.), Synapse Biomedical, Inc. (U.S.), EnteroMedics Inc (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), BioControl Medical (Israel), Accellent (U.S.), DynaMD (U.S.), Neurosigma, Inc. (U.S.), Soterix Medical, Inc. (U.S.), NeuroPace Inc. (U.S.) are the biggest neuromodulation device manufacturers in the market.

Browse Related Reports at:

Global Digital 3D Printing Market Research Report—Forecast till 2027

Global Influenza Vaccines Market Research Report—Forecast till 2027

Global Botulinum Toxin Market Research Report—Forecast till 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Herbal Medicines Market Dynamics, Trends and SWOT Analysis To 2027

Herbal Medicines Market Overview

Herbal Medicine Market is expected to flourish at a CAGR of 6.50% while garnering a market value of USD 136024.26 Million by 2023, predicts Market Research Future (MRFR). Herbal medicine demand is expected to grow significantly in the coming years due to a rising global population, according to MRFR's global market research study on herbal medicine. Another reason for the growth of the global herbal medicine market in the next few years is the growing public knowledge of the benefits of herbal medicines.

Toxin-free: Herbal medications as a result, the market for herbal medicines is expected to grow in the near future. In addition, they're a great value for the money. To put it another way, the industry is projected to pick up steam. Herbal medications are likely to see significant growth in the coming years due to rising research funding and investment. An additional benefit of the COVID-19 outbreak is that it has opened up significant business prospects for herbal medicine makers looking to expand their market share.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3250

However, the lack of standardisation in herbal medicines is expected to stifle industry growth in the future. A big obstacle to the market's expansion will be the adverse allergic reaction and the long-term outcomes of herbal medications.

Segmental Analysis

A large share of herbal medicine will be sold through hospitals and retail pharmacies, which is expected to be the largest distribution channel for herbal medicine in the future.

The herbal pharmaceutical segment of the global herbal medicine market is estimated to garner a sizable market share throughout the forecast period.

Regional Overview

According to MRFR's analysis on the herbal medicine business, Europe is expected to dominate the global market over the forecast period. During the study period, it is expected that rising investment and R&D in herbal medicines would be a prominent factor driving the market. Another important factor that could drive growth in the region's market is the rising incidence of chronic illness among the region's growing population.

As the world's population continues to grow and the incidence of chronic illness rises, the American market is expected to grow to the second-largest share by the end of the study period. Since herbal remedies are becoming more popular in the United States, it is expected to be a lucrative sector.

The increasing popularity of herbal medicines in APAC is expected to lead to the fastest growth in the region during the forecast period. In the evaluation period, India and China are predicted to be the most lucrative markets. Chemical-free and cheaper medicines are projected to play a role in the market's direction in the region, as well. Ayurveda has been practised in India since the Vedic era, making it a world-renowned source of herbal treatments. In addition, the Indian Government's increased investment and execution of supportive policies is expected to significantly grow the market throughout the evaluation period.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/herbal-medicine-market-3250

Competitive Dynamics

Due to the presence of several companies, the global market for herbal medicines is highly fragmented. Multiple prospects for market expansion are projected to arise as a result of the increasing use of medicinal plants, which will lead to an increase in new companies joining the market. Additionally, there are a number of regional businesses that contribute to the competitiveness of the market. They are producing herbal products and the increasing technological advancements in the herbal medicines sector are accelerating the market competitiveness. Additionally, the industry's efforts to extend its customer base are expected to expand its reach.

The notable players of the market are Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp., Arizona Natural Products, Blackmores, Himalaya Global Holdings Ltd, Dr. Willmar Schwabe India Pvt. Ltd.

Browse Related Reports at:

Medical Tourism Market Research Report - Global Forecast till 2027

CBD Market Research Report - Global Forecast till 2027

Surgical Equipment Market Research Report - Forecast to 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Aesthetics Market Profile, Key Players and Segmentation | Forecast to 2027

Aesthetics Market Overview

MRFR (Market Research Future) expects the aesthetics market to touch USD 12,175.1 MN by 2025. The global market will be expanding at a rate of 10.08% from 2020 to 2027 (review period).

Rising focus among people on looking younger and more fit raises the demand for a variety of aesthetic treatments, with this trend gaining popularity in developing countries as well. Aesthetic procedures such as Botox injections, liposuction, and nose reshaping have gained the attention of a surging number of consumers in Singapore, India, and South Korea.

The aesthetics industry is inundated with several renowned vendors that indulge in strategic competition, eyeing a better position. This leads to fierce rivalry in the aesthetic industry. The different strategies employed by the companies include mergers and acquisitions, new product launch, collaborations, agreements and more. To cite a reference, in December 2021, CUTERA INC., a reputed developer of light, laser, and various energy-based aesthetic devices, introduced an upgraded version of truSculpt flex, its popular muscle building technology. The truSculpt flex+ rapid treatment mode enhances the performance and quality of the Multi-Directional Stimulation, providing the same firming, strengthening, and toning results but in a fraction of the time.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3136

A major trend emerging in the worldwide market can be the surging demand for minimally invasive aesthetic procedures. On top of that, the mushrooming elderly population increasingly opting for a variety of aesthetic procedures also add to the market value. The emergence of new technically advanced and user-friendly devices coupled with the rising number of men opting for aesthetic treatment will further strengthen the market position in the ensuing years.

Market Segmentation

Procedures as well as end-user are the major segments that have been studied in the MRFR report, to present a detailed outline of the aesthetics industry.

Some of the key procedures include nonsurgical aesthetic procedures along with surgical aesthetic procedures.

The end users covered in the research study are salons & spas, hospitals & clinics, along with dermatology clinics & cosmetic centers.

Regional Insight

The aesthetics market has been regionally segregated into Europe, the Middle East & Africa or MEA coupled with the Americas, and Asia Pacific or APAC.

The Americas, divided into North America as well as Latin America, is the biggest market for aesthetics in the world. The American market’s dominance can be accredited to the highly developed healthcare sector in line with a sophisticated infrastructure. The soaring cases of skin disorders among people, surging popularity of a variety of cosmetic procedures and the extensive pool of skilled & board-certified medial staff and surgeons foster the market share in the region.

The European market for aesthetics can be split between Western Europe and Eastern Europe. Western Europe has a number of developed economies such as Germany, France, the UK, Spain, and Italy with well-defined, robust healthcare infrastructures. This, in addition to the high spending capacity of the consumers in these countries, makes Western Europe the better performing market in the region. The European market benefits from the strong support of the government in terms of funds and new initiatives, surge in research & development efforts and the leading vendors focusing on business expansion.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/aesthetics-market-3136

The Asia Pacific market is led by Japan, India, Australia, South Korea, and China. APAC will be thriving at the fastest rate between 2020 and 2027, given the soaring number of cosmetic professionals, and the escalating use of modern techniques. The availability of affordable treatment options attracts a huge number of overseas travellers, giving a significant boost to the medical tourism sector in the region.

Top Firms

Swisscode, SkinCeuticals, Endocare, Dermalogica, Kiehl’s, Clarins, Skin Medica, ZO Skin Health, Inc., Obagi Medical, Medik8, Neostrata, Biore, Alumier MD, Clinique, Elemis Ltd, PCA Skin, Lancome, IS Clinical, La Roche-Posay, Teoxane are some of the leading aesthetics devices and solutions providers in the worldwide market.

Browse Related Reports at:

Companion Diagnostics Market Research Report - Global Forecast till 2027

Intravenous (IV) Solution Market Research Report - Global Forecast till 2027

Concussions Market Research Report - Global Forecast till 2027

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com